stoxline Quote Chart Rank Option Currency Glossary
Inari Medical, Inc. (NARI)
45.9  -0.98 (-2.09%)    06-13 16:00
Open: 46.76
High: 47.2
Volume: 494,058
Pre. Close: 46.88
Low: 44.9203
Market Cap: 2,669(M)
Technical analysis
2024-06-13 4:45:04 PM
Short term     
Mid term     
Targets 6-month :  56.26 1-year :  60.85
Resists First :  48.17 Second :  52.09
Pivot price 48.87
Supports First :  41.81 Second :  34.79
MAs MA(5) :  47.08 MA(20) :  48.23
MA(100) :  47.43 MA(250) :  55.71
MACD MACD :  0.8 Signal :  1.4
%K %D K(14,3) :  22.6 D(3) :  27.4
RSI RSI(14): 45.8
52-week High :  71.84 Low :  36.72
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ NARI ] has closed above bottom band by 2.1%. Bollinger Bands are 35.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 47.29 - 47.56 47.56 - 47.85
Low: 44.19 - 44.48 44.48 - 44.79
Close: 45.34 - 45.86 45.86 - 46.41
Company Description

Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of deep vein thrombosis; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system, for treatment of pulmonary embolism. It also offers FlowSaver; FlowStasis, a large bore suture retention device designed to address various aspects of venous access site; and FlowTriever 2, a new disk shape designed to capture and remove wall adherent clot and shorten treatment. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.

Headline News

Thu, 13 Jun 2024
NARI Investors Have Opportunity to Lead Inari Medical, Inc. Securities Fraud Lawsuit - PR Newswire

Thu, 13 Jun 2024
Brown Capital Management LLC Sells 1256 Shares of Inari Medical, Inc. (NASDAQ:NARI) - Defense World

Thu, 13 Jun 2024
Clear Street Markets LLC Invests $198000 in Inari Medical, Inc. (NASDAQ:NARI) - Defense World

Wed, 12 Jun 2024

Wed, 12 Jun 2024
Should You Investigate Inari Medical, Inc. (NASDAQ:NARI) At US$78.20? - Yahoo New Zealand News

Tue, 11 Jun 2024
NARI Investors Have Opportunity to Lead Inari Medical, Inc. Securities Fraud Lawsuit - PR Newswire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Medical - Devices
Shares Out 58 (M)
Shares Float 50 (M)
Held by Insiders 9.4 (%)
Held by Institutions 102.5 (%)
Shares Short 4,840 (K)
Shares Short P.Month 3,960 (K)
Stock Financials
EPS -0.41
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 7.71
Profit Margin -4.6 %
Operating Margin -5.7 %
Return on Assets (ttm) -0.7 %
Return on Equity (ttm) -5.5 %
Qtrly Rev. Growth 23.2 %
Gross Profit (p.s.) 0
Sales Per Share 8.95
EBITDA (p.s.) -0.02
Qtrly Earnings Growth 0 %
Operating Cash Flow 26 (M)
Levered Free Cash Flow 47 (M)
Stock Valuations
PE Ratio -111.96
PEG Ratio -1.1
Price to Book value 5.95
Price to Sales 5.12
Price to Cash Flow 104.04
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android